Presenter(s)
Sarah Wiant, Erica D'Aquila, Elizabeth Garcia, and Katey King
Organization
NYC DOHMH
Presentation Event
2022 National Ryan White Conference on HIV Care & Treatment
Track
Population-Based Approaches for Improving Access, Engagement / Reengagement, and Health Outcomes
Abstract No.
20444
Description
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.